Risk of cancer in patients with autoimmune pancreatitis

American Journal of Gastroenterology

Volumn 108, Issue 4, 2013, Pages 610-617

  Shiokawa, Masahiro ^a   Kodama, Yuzo ^a   Yoshimura, Kenichi ^b   Kawanami, Chiharu ^c   Mimura, Jun ^d   Yamashita, Yukitaka ^e   Asada, Masanori ^f   Kikuyama, Masataka ^g   Okabe, Yoshihiro ^h   Inokuma, Tetsuro ⁱ   Ohana, Masaya ^j   Kokuryu, Hiroyuki ^k   Takeda, Kazuo ^l   Tsuji, Yoshihisa ^m   Minami, Ryuki ^k   Sakuma, Yojiro ^k   Kuriyama, Katsutoshi ^k   Ota, Yuji ^k   Tanabe, Wataru ^k   Maruno, Takahisa ^a   Kurita, Akira ^a   Sawai, Yugo ^a   Uza, Norimitsu ^a   Watanabe, Tomohiro ^a   Haga, Hironori ^b   Chiba, Tsutomu ^a   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c OTSU RED CROSS HOSPITAL   (Japan)

^d NISHI KOBE MEDICAL CENTER   (Japan)

^e JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^f Kitano Hospital   (Japan)

^g SHIZUOKA GENERAL HOSPITAL   (Japan)

^h OSAKA RED CROSS HOSPITAL   (Japan)

ⁱ KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^j TENRI HOSPITAL   (Japan)

^k KYOTO KATSURA HOSPITAL   (Japan)

^l KYOTO INDUSTRIAL HEALTH ASSOCIATION   (Japan)

^m MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT CANCER; CANCER RISK; CANCER THERAPY; CELL INFILTRATION; COHORT ANALYSIS; COLON CANCER; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; STROMA; THYROID CANCER;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PANCREATITIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMACH NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84875939025     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.465     Document Type: Article

References (41)

1. Finkelberg DL, Sahani D, Deshpande V et al. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-6.
2. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
3. Chiba T. Are immunoglobulin G4-positive multiorgan lymphoproliferative syndrome and autoimmune pancreatitis diff erent manifestations of a common clinicopathologic entity? Gastroenterology 2010; 138: 781-4.
4. Inoue H, Miyatani H, Sawada Y et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33: 208-9.
5. Loos M, Esposito I, Hedderich DM et al. Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: a case report and review of the literature. Pancreas 2011; 40: 151-4.
6. Pezzilli R, Vecchiarelli S, Di Marco MC et al. Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. Case Rep Gastroenterol 2011; 5: 378-85.
7. Kim T, Grobmyer SR, Dixon LR et al. Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: not just a coincidence? J Gastrointest Surg 2008; 12: 1566-70.
8. Takahashi N, Ghazale AH, Smyrk TC et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 2009; 38: 523-6.
9. Oh HC, Kim JG, Kim JW et al. Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med 2008; 47: 2025-8.
10. Arai O, Matsueda K, Katayama S et al. Case of autoimmune pancreatitis with various extrapancreatic fibrosclerosis followed by malignant diseases. Nihon Shokakibyo Gakkai Zasshi 2008; 105: 711-8.
11. Nishino T, Toki F, Oyama H et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45: 497-501.
12. Ito M, Naruke Y, Mihara Y et al. Th yroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease. Pathol Int 2011; 61: 589-92.
13. Yamamoto M, Takahashi H, Tabeya T et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol 2012; 22: 414-8.
14. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006; 18: 129-34.
15. Szekanecz E, Andras C, Sandor Z et al. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmun Rev 2006; 6: 42-7.
16. Szekanecz Z, Szekanecz E, Bako G et al. Malignancies in autoimmune rheumatic diseases-a mini-review. Gerontology 2011; 57: 3-10.
17. Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer-a population-based study. N Engl J Med 1990; 323: 1228-33.
18. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004; 126: 1634-48.
19. Sandanayake NS, Church NI, Chapman MH et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7: 1089-96.
20. Buchbinder R, Forbes A, Hall S et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-95.
21. Zahr ZA, Baer AN. Malignancy in myositis. Curr Rheumatol Rep 2011; 13: 208-15.
22. Sigurgeirsson B, Lindelof B, Edhag O et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-7.
23. Andras C, Ponyi A, Constantin T et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008; 35: 438-44.
24. Otsuki M, Chung JB, Okazaki K et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008; 43: 403-8.
25. Okazaki K, Uchida K, Koyabu M et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011; 46: 277-88.
26. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol 2007; 42 (Suppl 18): 39-41.
27. Chari ST, Murray JA. Autoimmune pancreatitis, Part II: the relapse. Gastroenterology 2008; 134: 625-8.
28. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007; 56: 1650-2.
29. Matsuda T, Marugame T, Kamo KI et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2012; 42: 139-47.
30. Kamisawa T, Funata N, Hayashi Y et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 683-7.
31. Kamisawa T, Funata N, Hayashi Y et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
32. Axon A. Review article: gastric cancer and Helicobacter pylori. Aliment Pharmacol Ther 2002; 16 (Suppl 4): 83-8.
33. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
34. Ponyi A, Constantin T, Garami M et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci 2005; 1051: 64-71.
35. Azuma K, Yamada H, Ohkubo M et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol 2011; 21: 178-83.
36. Watanabe T, Yamashita K, Fujikawa S et al. Activation of toll-like receptors and NOD-like receptors is involved in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum 2012; 64: 914-24.
37. Apetoh L, Ghiringhelli F, Tesniere A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-9.
38. Curtin JF, Liu N, Candolfi M et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 2009; 6: e10.
39. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006; 66: 10233-7.
40. Naitoh I, Nakazawa T, Ohara H et al. Comparative evaluation of the Japanese diagnostic criteria for autoimmune pancreatitis. Pancreas 2010; 39: 1173-9.
41. Okazaki K, Uchida K, Matsushita M et al. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007; 42 (Suppl 18): 32-8.